Zavesca (miglustat)

miglustat · Actelion Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zavesca (miglustat), covering 2016-05-19 to 2016-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis [Phase 2]